Found: 14
Select item for more details and to access through your institution.
Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 6, p. 1094, doi. 10.1007/s00535-013-0864-4
- By:
- Publication type:
- Article
Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.
- Published in:
- Journal of Medical Virology, 2010, v. 82, n. 1, p. 41, doi. 10.1002/jmv.21629
- By:
- Publication type:
- Article
Change of hepatitis B virus genotypes in acute and chronic infections in Japan.
- Published in:
- Journal of Medical Virology, 2008, v. 80, n. 11, p. 1880, doi. 10.1002/jmv.21309
- By:
- Publication type:
- Article
Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine.
- Published in:
- Journal of Medical Virology, 2007, v. 79, n. 10, p. 1472, doi. 10.1002/jmv.20994
- By:
- Publication type:
- Article
Response to long‐term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C.
- Published in:
- Journal of Medical Virology, 2006, v. 78, n. 10, p. 1276
- By:
- Publication type:
- Article
Clinical and virological features of non‐breakthrough and severe exacerbation due to lamivudine‐resistant hepatitis B virus mutants.
- Published in:
- Journal of Medical Virology, 2006, v. 78, n. 3, p. 341
- By:
- Publication type:
- Article
Predictive factors of virological non‐response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load.
- Published in:
- Journal of Medical Virology, 2006, v. 78, n. 1, p. 83
- By:
- Publication type:
- Article
Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients.
- Published in:
- Hepatology Research, 2013, v. 43, n. 7, p. 691, doi. 10.1111/hepr.12009
- By:
- Publication type:
- Article
Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment.
- Published in:
- Hepatology Research, 2010, v. 40, n. 2, p. 125, doi. 10.1111/j.1872-034X.2009.00565.x
- By:
- Publication type:
- Article
Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks.
- Published in:
- Hepatology Research, 2009, v. 39, n. 11, p. 1056, doi. 10.1111/j.1872-034X.2009.00548.x
- By:
- Publication type:
- Article
Changes in viral loads of lamivudine-resistant mutants during entecavir therapy.
- Published in:
- Hepatology Research, 2008, v. 38, n. 2, p. 132, doi. 10.1111/j.1872-034X.2007.00144.x
- By:
- Publication type:
- Article
Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir.
- Published in:
- Drug Design, Development & Therapy, 2014, v. 8, p. 869, doi. 10.2147/DDDT.S65349
- By:
- Publication type:
- Article
Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy.
- Published in:
- Intervirology, 2005, v. 48, n. 6, p. 372, doi. 10.1159/000086064
- By:
- Publication type:
- Article
Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2010, v. 25, n. 5, p. 892, doi. 10.1111/j.1440-1746.2009.06161.x
- By:
- Publication type:
- Article